Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Wow

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jan 27, 2021 11:32am

53 Views

Post# 32399070

RE:RE:RE:RE:RE:Wow

Don't forget Vaxil has a inverse correlation to the S & P index !!!

Bio technology will save the rest of the economy !!!

CamaroZL1 wrote:

Red~One wrote: NEW YORK/LONDON (Reuters) - Stocks fell and the dollar rose on Wednesday as investors turned more cautious about COVID-19 and stretched stock valuations, with the U.S Federal Reserve meeting and a glut of corporate earnings also in focus.